{"id":"https://openalex.org/W2015263236","doi":"https://doi.org/10.1016/j.pain.2008.04.006","title":"The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain","display_name":"The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain","publication_year":2008,"publication_date":"2008-05-29","ids":{"openalex":"https://openalex.org/W2015263236","doi":"https://doi.org/10.1016/j.pain.2008.04.006","mag":"2015263236","pmid":"https://pubmed.ncbi.nlm.nih.gov/18502582"},"language":"en","primary_location":{"id":"doi:10.1016/j.pain.2008.04.006","doi":"https://doi.org/10.1016/j.pain.2008.04.006","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.pain.2008.04.006","pdf_url":null,"source":{"id":"https://openalex.org/S140848990","display_name":"Pain","issn_l":"0304-3959","issn":["0304-3959","1872-6623"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pain","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019489860","display_name":"Penny C. Staton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Penny C. Staton","raw_affiliation_strings":["Neurology Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, UK Discovery Technology Group, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex CM19 5AW, UK Molecular Discovery Research, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex CM19 5AW, UK Laboratory Animal Sciences, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex CM19 5AW, UK","Neurology Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, UK","fax: +44 (0)1279 622555"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, UK Discovery Technology Group, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex CM19 5AW, UK Molecular Discovery Research, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex CM19 5AW, UK Laboratory Animal Sciences, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex CM19 5AW, UK","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":"Neurology Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, UK","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":"fax: +44 (0)1279 622555","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110077902","display_name":"Jonathan P. Hatcher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jon P. Hatcher","raw_affiliation_strings":["Neurology Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Deborah J. Walker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]},{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Deborah J. Walker","raw_affiliation_strings":["Discovery Technology Group, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex CM19 5AW, UK","Present address: Wolfson Centre for Age-Related Diseases, King\u2019s College London, London SE1 1UL, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Technology Group, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex CM19 5AW, UK","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":"Present address: Wolfson Centre for Age-Related Diseases, King\u2019s College London, London SE1 1UL, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023070129","display_name":"Alastair Morrison","orcid":"https://orcid.org/0000-0002-8654-8215","observed_orcids":["https://orcid.org/0000-0002-8654-8215"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alastair D. Morrison","raw_affiliation_strings":["Discovery Technology Group, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex CM19 5AW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Technology Group, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex CM19 5AW, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062680972","display_name":"Ellen M. Shapland","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ellen M. Shapland","raw_affiliation_strings":["Discovery Technology Group, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex CM19 5AW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Technology Group, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex CM19 5AW, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113665486","display_name":"Jane P. Hughes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jane P. Hughes","raw_affiliation_strings":["Neurology Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Elizabeth Chong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Elizabeth Chong","raw_affiliation_strings":["Neurology Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, UK","Present address: NGI CEDD Cognition and Neurodegeneration Centre, 11 Biopolis Way, The Helios, #03-01/02, Singapore 138667, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, UK","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":"Present address: NGI CEDD Cognition and Neurodegeneration Centre, 11 Biopolis Way, The Helios, #03-01/02, Singapore 138667, Singapore","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083868830","display_name":"Palwinder K. Mander","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Palwinder K. Mander","raw_affiliation_strings":["Neurology Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063728506","display_name":"Paula J. Green","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paula J. Green","raw_affiliation_strings":["Neurology Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026721816","display_name":"Andy Billinton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andy Billinton","raw_affiliation_strings":["Neurology Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046207156","display_name":"Michael Fulleylove","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Michael Fulleylove","raw_affiliation_strings":["Laboratory Animal Sciences, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex CM19 5AW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory Animal Sciences, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex CM19 5AW, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011468603","display_name":"Hilary C. Lancaster","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Hilary C. Lancaster","raw_affiliation_strings":["Laboratory Animal Sciences, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex CM19 5AW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory Animal Sciences, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex CM19 5AW, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079558058","display_name":"J. Smith","orcid":"https://orcid.org/0000-0003-0609-6237","observed_orcids":["https://orcid.org/0000-0003-0609-6237"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jason C. Smith","raw_affiliation_strings":["Laboratory Animal Sciences, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex CM19 5AW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory Animal Sciences, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex CM19 5AW, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057976291","display_name":"Leigh T. Bailey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Leigh T. Bailey","raw_affiliation_strings":["Laboratory Animal Sciences, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex CM19 5AW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory Animal Sciences, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex CM19 5AW, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Alan Wise","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alan Wise","raw_affiliation_strings":["Molecular Discovery Research, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex CM19 5AW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Discovery Research, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex CM19 5AW, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044317445","display_name":"Andrew J. Brown","orcid":"https://orcid.org/0000-0002-5616-3664","observed_orcids":["https://orcid.org/0000-0002-5616-3664"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andrew J. Brown","raw_affiliation_strings":["Molecular Discovery Research, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex CM19 5AW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Discovery Research, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex CM19 5AW, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062777125","display_name":"Jill C. Richardson","orcid":"https://orcid.org/0000-0001-6564-3187","observed_orcids":["https://orcid.org/0000-0001-6564-3187"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jill C. Richardson","raw_affiliation_strings":["Neurology Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036338186","display_name":"Iain P. Chessell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Iain P. Chessell","raw_affiliation_strings":["Neurology Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, UK","institution_ids":["https://openalex.org/I188950975"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5019489860"],"corresponding_institution_ids":["https://openalex.org/I188950975"],"apc_list":null,"apc_paid":null,"fwci":13.2985,"has_fulltext":false,"cited_by_count":276,"citation_normalized_percentile":{"value":0.99447606,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"139","issue":"1","first_page":"225","last_page":"236"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.6762999892234802,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.6762999892234802,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10414","display_name":"Cannabis and Cannabinoid Research","score":0.3188000023365021,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11204","display_name":"Ion Channels and Receptors","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2809","display_name":"Sensory Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gpr55","display_name":"GPR55","score":0.996999979019165},{"id":"https://openalex.org/keywords/cannabinoid-receptors","display_name":"cannabinoid receptors","score":0.8519999980926514},{"id":"https://openalex.org/keywords/mechanical-hyperalgesia","display_name":"mechanical hyperalgesia","score":0.9390000104904175},{"id":"https://openalex.org/keywords/inflammatory-pain","display_name":"inflammatory pain","score":0.9919999837875366},{"id":"https://openalex.org/keywords/neuropathic-pain","display_name":"neuropathic pain","score":1.0},{"id":"https://openalex.org/keywords/adjuvant-induced-inflammation","display_name":"adjuvant-induced inflammation","score":0.8109999895095825},{"id":"https://openalex.org/keywords/cytokine-expression","display_name":"cytokine expression","score":0.7149999737739563},{"id":"https://openalex.org/keywords/pain-relief","display_name":"analgesia","score":0.671999990940094}],"concepts":[{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.692522406578064},{"id":"https://openalex.org/C2780871563","wikidata":"https://www.wikidata.org/wiki/Q422936","display_name":"Cannabinoid","level":3,"score":0.6820684671401978},{"id":"https://openalex.org/C2779245659","wikidata":"https://www.wikidata.org/wiki/Q1633866","display_name":"Hyperalgesia","level":4,"score":0.6412242650985718},{"id":"https://openalex.org/C2777107010","wikidata":"https://www.wikidata.org/wiki/Q2798704","display_name":"Neuropathic pain","level":2,"score":0.6352275013923645},{"id":"https://openalex.org/C148001335","wikidata":"https://www.wikidata.org/wiki/Q421237","display_name":"Cannabinoid receptor","level":4,"score":0.6278293132781982},{"id":"https://openalex.org/C93248783","wikidata":"https://www.wikidata.org/wiki/Q21150595","display_name":"Cannabinoid receptor type 2","level":5,"score":0.5562646985054016},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.46485793590545654},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.4398079812526703},{"id":"https://openalex.org/C2780820201","wikidata":"https://www.wikidata.org/wiki/Q173235","display_name":"Analgesic","level":2,"score":0.43177300691604614},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3889092206954956},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3305421471595764},{"id":"https://openalex.org/C15490471","wikidata":"https://www.wikidata.org/wiki/Q2734305","display_name":"Nociception","level":3,"score":0.29410749673843384},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.24130794405937195},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1417543888092041},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.06413581967353821}],"mesh":[{"descriptor_ui":"D000595","descriptor_name":"Amino Acid Sequence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001483","descriptor_name":"Base Sequence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006930","descriptor_name":"Hyperalgesia","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D006930","descriptor_name":"Hyperalgesia","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D008026","descriptor_name":"Ligation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008969","descriptor_name":"Molecular Sequence Data","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009437","descriptor_name":"Neuralgia","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009437","descriptor_name":"Neuralgia","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D010147","descriptor_name":"Pain Measurement","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D010812","descriptor_name":"Physical Stimulation","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D018345","descriptor_name":"Mice, Knockout","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018836","descriptor_name":"Inflammation Mediators","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018836","descriptor_name":"Inflammation Mediators","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D043882","descriptor_name":"Receptors, Cannabinoid","qualifier_ui":"Q000172","qualifier_name":"deficiency","is_major_topic":false},{"descriptor_ui":"D043882","descriptor_name":"Receptors, Cannabinoid","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D043882","descriptor_name":"Receptors, Cannabinoid","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.pain.2008.04.006","doi":"https://doi.org/10.1016/j.pain.2008.04.006","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.pain.2008.04.006","pdf_url":null,"source":{"id":"https://openalex.org/S140848990","display_name":"Pain","issn_l":"0304-3959","issn":["0304-3959","1872-6623"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pain","raw_type":"journal-article"},{"id":"pmid:18502582","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18502582","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pain","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W1491647768","https://openalex.org/W1570565174","https://openalex.org/W1578252886","https://openalex.org/W1597638054","https://openalex.org/W1819429514","https://openalex.org/W1824285398","https://openalex.org/W1964037009","https://openalex.org/W1965215187","https://openalex.org/W1966146877","https://openalex.org/W1968412196","https://openalex.org/W1977183929","https://openalex.org/W1980122275","https://openalex.org/W1980990150","https://openalex.org/W1991319303","https://openalex.org/W1997310048","https://openalex.org/W1998141662","https://openalex.org/W1999808927","https://openalex.org/W2000895369","https://openalex.org/W2002785222","https://openalex.org/W2004468399","https://openalex.org/W2007755013","https://openalex.org/W2008580491","https://openalex.org/W2014455177","https://openalex.org/W2015614945","https://openalex.org/W2016639534","https://openalex.org/W2018656586","https://openalex.org/W2026013579","https://openalex.org/W2028841248","https://openalex.org/W2030368271","https://openalex.org/W2030657137","https://openalex.org/W2033931579","https://openalex.org/W2039106853","https://openalex.org/W2040509064","https://openalex.org/W2046550691","https://openalex.org/W2056188558","https://openalex.org/W2067924690","https://openalex.org/W2072369247","https://openalex.org/W2075894678","https://openalex.org/W2080086221","https://openalex.org/W2080089439","https://openalex.org/W2082433795","https://openalex.org/W2092643285","https://openalex.org/W2119826244","https://openalex.org/W2124248227","https://openalex.org/W2130240486","https://openalex.org/W2131899215","https://openalex.org/W2144748383","https://openalex.org/W2161820607","https://openalex.org/W2256167805"],"related_works":["https://openalex.org/W2605767320","https://openalex.org/W4323543289","https://openalex.org/W4281481596","https://openalex.org/W4205331895","https://openalex.org/W7135446775","https://openalex.org/W3136039090","https://openalex.org/W4402139988","https://openalex.org/W2210409717","https://openalex.org/W3120355575","https://openalex.org/W2087757288"],"abstract_inverted_index":{"It":[0],"has":[1,43],"been":[2,44],"postulated":[3],"that":[4,16,126,159,207],"the":[5,17,20,31,66,91,146,153,164,174,181,185,208,217],"G":[6],"protein-coupled":[7],"receptor,":[8],"GPR55,":[9],"is":[10],"a":[11,54],"third":[12],"cannabinoid":[13],"receptor.":[14],"Given":[15],"ligands":[18],"at":[19,127],"CB(1)":[21],"and":[22,28,40,62,96,141,169,222],"CB(2)":[23],"receptors":[24],"are":[25,48],"effective":[26],"analgesic":[27],"anti-inflammatory":[29],"agents,":[30],"role":[32],"of":[33,72,93,103,136,166,176,187,210,219],"GPR55":[34,51,55,160,211],"in":[35,90,114,143,180,216],"hyperalgesia":[36,110,179,197],"associated":[37],"with":[38,81,152],"inflammatory":[39,108,177,221],"neuropathic":[41,188,223],"pain":[42],"investigated.":[45],"As":[46],"there":[47,132],"no":[49,76],"well-validated":[50],"tool":[52],"compounds,":[53],"knockout":[56],"(GPR55(-/-))":[57],"mouse":[58],"line":[59],"was":[60,111],"generated":[61],"fully":[63],"backcrossed":[64],"onto":[65],"C57BL/6":[67],"strain.":[68],"General":[69],"phenotypic":[70],"analysis":[71],"GPR55(-/-)":[73,85,115,148,182,190],"mice":[74,86,116,149,191],"revealed":[75],"obvious":[77],"primary":[78],"differences,":[79],"compared":[80,151],"wild-type":[82],"(GPR55(+/+))":[83],"littermates.":[84],"were":[87,133],"then":[88],"tested":[89],"models":[92],"adjuvant-induced":[94],"inflammation":[95],"partial":[97],"nerve":[98],"ligation.":[99],"Following":[100],"intraplantar":[101],"administration":[102],"Freund's":[104],"complete":[105],"adjuvant":[106],"(FCA),":[107],"mechanical":[109,178,196],"completely":[112],"absent":[113],"up":[117,198],"to":[118,173,194,199],"14":[119,128],"days":[120,129,201],"post-injection.":[121],"Cytokine":[122],"profiling":[123],"experiments":[124],"showed":[125],"post-FCA":[130],"injection":[131],"increased":[134],"levels":[135],"IL-4,":[137],"IL-10,":[138],"IFN":[139],"gamma":[140],"GM-CSF":[142],"paws":[144],"from":[145],"FCA-injected":[147,154],"when":[150],"GPR55(+/+)":[155],"mice.":[156,183],"This":[157],"suggests":[158],"signalling":[161],"can":[162],"influence":[163],"regulation":[165],"certain":[167],"cytokines":[168],"this":[170],"may":[171,212],"contribute":[172],"lack":[175],"In":[184],"model":[186],"hypersensitivity,":[189],"also":[192],"failed":[193],"develop":[195],"28":[200],"post-ligation.":[202],"These":[203],"data":[204],"clearly":[205],"suggest":[206],"manipulation":[209],"have":[213],"therapeutic":[214],"potential":[215],"treatment":[218],"both":[220],"pain.":[224]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":15},{"year":2023,"cited_by_count":12},{"year":2022,"cited_by_count":16},{"year":2021,"cited_by_count":21},{"year":2020,"cited_by_count":18},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":21},{"year":2016,"cited_by_count":15},{"year":2015,"cited_by_count":16},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":14},{"year":2012,"cited_by_count":24}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}